LONDON--(BUSINESS WIRE)--According to the latest market research report by Technavio, the global tissue heart valves market is expected to reach close to USD 1.25 billion by 2020.
In this report, Technavio covers the present scenario and growth prospects of the Global Tissue Heart Valves Market for 2016-2020. To calculate the market size, the report considers the consumption value of construction tractors worldwide.
“APAC has a large patient pool. Cardiovascular diseases are becoming prevalent in the region with each year with high mortality rates. It is estimated that about 20,000 people in the region died from cardiovascular diseases, accounting for 30% of the overall chronic diseases-related deaths. To cope with this challenge, developing countries such as India and China have enhanced their healthcare infrastructure, and it has resulted in the availability of high-quality treatment options, and this trend will boost market growth over the forecast period,” said Barath Palada, one of Technavio’s lead industry analysts for cardiovascular devices.
Ad Statistics
Times Displayed: 349388
Times Visited: 21070 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Global tissue heart valves market segmentation by geography 2015
• Americas 41.83%
• EMEA 36%
• APAC 22.17%
Source: Technavio research
Request sample report: http://bit.ly/1RxBvBq
Tissue heart valves market in Americas: largest market
The tissue heart valves market in the Americas generated close to USD 435 million in 2015. Incidence of heart valve diseases is on the rise in the Americas, particularly in the US, Canada, and Brazil. It is estimated that cardiac disorders account for more than 450,000 deaths in the US each year, and about 1.5 million people in the US have aortic stenosis, with 85,000 undergoing tissue heart valve replacement procedure each year. As of 2015, 33% of the US population may likely undergo heart valve therapy. Implementation of MI tissue heart valve replacement procedures have significantly helped reduce the recovery time in these procedures. As these procedures also reduced bleeding complications, pain, and scarring its popularity is likely to further soar in the region over the forecast period.
Tissue heart valves market in EMEA
The tissue heart valves market in EMEA generated close to USD 374.4 million in 2015. The UK, Germany, and France emerged as the key contributors to the market in 2015. Incidences of heart valve diseases in the region is on the rise. It is estimated that 25% of the people aged above 65 have aortic stenosis, a type of heart valve disease in the region.
In 2011, research statistics estimated that medical facilities performed close to 283 per million aortic valve replacement procedures in Belgium, 311 per million in Germany, and 137 per million in France and the UK. As the trend is likely to persist, the market will witness a growing demand for tissue heart valves during the forecast period.
